Claude Mwamba
Overview
Explore the profile of Claude Mwamba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakisingi C, Mwamba C, Kasongo Muteba M, Kasamba E, Kabamba M, Tanon A, et al.
Risk Manag Healthc Policy
. 2024 Jan;
17:171-180.
PMID: 38250217
Background: Tuberculosis and diabetes mellitus are major public health challenges worldwide. The two scourges have bidirectional relationship with high morbidity and mortality. Objective: The present study was conducted to determine...
2.
Kakisingi C, Kabamba M, Muteba M, Tamunbango H, Tanon A, Situakibanza H, et al.
J Multidiscip Healthc
. 2023 Jun;
16:1577-1586.
PMID: 37309538
Background: Tuberculosis-Diabetes mellitus (TB-DM) co-morbidity is a growing scourge in the world. The new approaches and interventions for TB control implemented by the Tuberculosis National Control Program (TNCP) in DRC...
3.
Kakisingi C, Muteba M, Mukuku O, Kyabu V, Ngwej K, Kajimb P, et al.
Pan Afr Med J
. 2020 Oct;
36:280.
PMID: 33088409
Introduction: female sex workers FSWs) are considered a high-risk group for acquiring HIV infection due to their HIV prevalence estimated to be 10-20 times higher than in woman in the...
4.
Clumeck N, Mwamba C, Kabeya K, Matanda S, Vaira D, Necsoi C, et al.
AIDS
. 2014 Jul;
28(8):1143-53.
PMID: 25028911
Objective: To compare WHO first-line antiretroviral therapy (ART) with nonnucleoside reverse transcriptase inhibitors (NNRTI)-based regimen with a boosted protease inhibitor (bPI) regimen in a resource-limited setting regarding treatment outcome and...